Skip to main content
icon for 海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？
政治·特朗普

海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？

icon for 海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？
政治·特朗普

海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？

$14,094 交易量

2026-09-30
Polymarket

$14,094 交易量

Polymarket

9月30日

$7,146 交易量

21%

10月31日

$3,427 交易量

35%

11月30日

$1,029 交易量

36%

12月31日

$2,492 交易量

40%

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.President Trump nominated White House domestic policy aide Dr. Heidi Overton on August 19, 2026, to serve as FDA commissioner following the May resignation of Dr. Marty Makary. The Senate Health, Education, Labor and Pensions Committee must first advance the nomination before a full Senate vote. Committee chairman Sen. Bill Cassidy voiced immediate strong reservations over Overton’s involvement in a recent executive order on childhood vaccines, describing it as nearly disqualifying and signaling potential hurdles even among Republicans. Democratic members, including Sen. Patty Murray, have signaled opposition. Confirmation would require navigating committee scrutiny and securing sufficient Republican support in a process that can shift with additional statements or hearing developments.

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.

The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.

The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
交易量
$14,094
結束日期
2027-01-01
市場開放時間
Aug 20, 2026, 5:43 PM ET

Resolver

0x65070BE91...
This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.President Trump nominated White House domestic policy aide Dr. Heidi Overton on August 19, 2026, to serve as FDA commissioner following the May resignation of Dr. Marty Makary. The Senate Health, Education, Labor and Pensions Committee must first advance the nomination before a full Senate vote. Committee chairman Sen. Bill Cassidy voiced immediate strong reservations over Overton’s involvement in a recent executive order on childhood vaccines, describing it as nearly disqualifying and signaling potential hurdles even among Republicans. Democratic members, including Sen. Patty Murray, have signaled opposition. Confirmation would require navigating committee scrutiny and securing sufficient Republican support in a process that can shift with additional statements or hearing developments.

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.

The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.

The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
交易量
$14,094
結束日期
2027-01-01
市場開放時間
Aug 20, 2026, 5:43 PM ET

Resolver

0x65070BE91...
This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.

相關

icon for 馮德萊恩將於2026年卸任歐盟委員會主席？

馮德萊恩將於2026年卸任歐盟委員會主席？

4%
是
icon for 國會會在2026年推翻任何否決權嗎？

國會會在2026年推翻任何否決權嗎？

6%
是
icon for Howard Lutnick out as Secretary of Commerce by December 31?

Howard Lutnick out as Secretary of Commerce by December 31?

32%

警惕外部連結哦。

Frequently Asked Questions

"海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？" is a prediction market on Polymarket with 4 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "12月31日" at 40%, followed by "11月30日" at 36%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 40¢ implies that the market collectively assigns a 40% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？" has generated $14.1K in total trading volume since the market launched on Aug 20, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？," browse the 4 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？" is "12月31日" at 40%, meaning the market assigns a 40% chance to that outcome. The next closest outcome is "11月30日" at 36%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.